.jpg)
Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the First North 25 Index, (Nasdaq Stockholm: FN25), which will become effective at market open on Monday, January 4, 2021.
The following securities will be added to the Index:
| Symbol | Security Name |
| AZELIO | Azelio AB |
| EG7 | Enad Global 7 AB |
| IMP A SDB | Implantica AG SDB ser. A |
| LYKO A | Lyko Group AB ser. A |
| NANOFH | Nanoform Finland Oyj |
| OFFHUS | Offentliga Hus i Norden AB |
| SECARE | Swedencare AB |
| SEYE | Smart Eye AB |
| SIVE | Sivers Semiconductors AB |
The following securities will be removed from the Index:
| Symbol | Security Name |
| ABSO | Absolent Group AB |
| CLIME B | Climeon AB ser. B |
| DETEC | Detection Technology Oyj |
| ENZY | Enzymatica AB |
| FARON | Faron Pharmaceuticals Oy |
| GENO | Genovis AB |
| MNTC | Mentice AB |
| OVZON | Ovzon AB |
| SPEC | SpectaCure |
The First North 25 Index measures the performance of a selection of the largest and most traded securities listed on the Nasdaq First North Growth Markets in Denmark, Finland, Iceland and Sweden. The Index is reviewed semi-annually in January and July. For more information please refer to the First North 25 Index Methodology.
